Global IoT Spending for Connected Devices, Platforms, Digital Services in Pharmaceutical Manufacturing Market Insights and Forecast to 2028

Pharma companies use IoT technologies in manufacturing plants to aid in the process of continuous manufacturing. Continuous manufacturing helps pharma companies to significantly cut cost and time in manufacturing and enhance product quality. IoT helps in the standardization of the manufacturing process along with data integrity. IoT provides visibility from production to distribution in a manufacturing plant, leading to better and feasible analysis of the processes thereby increasing operational efficiency.
Market Analysis and Insights: Global IoT Spending for Connected Devices, Platforms, Digital Services in Pharmaceutical Manufacturing Market
The global IoT Spending for Connected Devices, Platforms, Digital Services in Pharmaceutical Manufacturing market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Medical Device accounting for % of the IoT Spending for Connected Devices, Platforms, Digital Services in Pharmaceutical Manufacturing global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Clinical Trials segment is altered to an % CAGR throughout this forecast period.
China IoT Spending for Connected Devices, Platforms, Digital Services in Pharmaceutical Manufacturing market size is valued at US$ million in 2021, while the North America and Europe IoT Spending for Connected Devices, Platforms, Digital Services in Pharmaceutical Manufacturing are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe IoT Spending for Connected Devices, Platforms, Digital Services in Pharmaceutical Manufacturing landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global IoT Spending for Connected Devices, Platforms, Digital Services in Pharmaceutical Manufacturing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global IoT Spending for Connected Devices, Platforms, Digital Services in Pharmaceutical Manufacturing market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global IoT Spending for Connected Devices, Platforms, Digital Services in Pharmaceutical Manufacturing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global IoT Spending for Connected Devices, Platforms, Digital Services in Pharmaceutical Manufacturing market.
Global IoT Spending for Connected Devices, Platforms, Digital Services in Pharmaceutical Manufacturing Scope and Market Size
IoT Spending for Connected Devices, Platforms, Digital Services in Pharmaceutical Manufacturing market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global IoT Spending for Connected Devices, Platforms, Digital Services in Pharmaceutical Manufacturing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Medical Device
System and Software
Service
Connectivity Technology
Segment by Application
Clinical Trials
Drug Disclosure
Drug Manufacturing
Drug Supply Chain
By Company
PTC
Medtronic
Philips
Cisco Systems
IBM Corporation
GE Healthcare
Microsoft Corporation
SAP SE
Qualcomm Life
Honeywell Life Care Solutions
Stanley Healthcare
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA